KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) Other Non Operating Income (2016 - 2022)

HCA Healthcare (HCA) has disclosed Other Non Operating Income for 11 consecutive years, with -$78.0 million as the latest value for Q2 2022.

  • For Q2 2022, Other Non Operating Income fell 550.0% year-over-year to -$78.0 million; the TTM value through Jun 2023 reached -$78.0 million, up 13.33%, while the annual FY2022 figure was -$78.0 million, 550.0% down from the prior year.
  • Other Non Operating Income hit -$78.0 million in Q2 2022 for HCA Healthcare, down from -$12.0 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at -$9.0 million in Q3 2018 and bottomed at -$295.0 million in Q1 2020.
  • Average Other Non Operating Income over 5 years is -$121.0 million, with a median of -$78.0 million recorded in 2022.
  • Year-over-year, Other Non Operating Income soared 76.92% in 2018 and then crashed 2244.44% in 2019.
  • HCA Healthcare's Other Non Operating Income stood at -$9.0 million in 2018, then plummeted by 2244.44% to -$211.0 million in 2019, then plummeted by 39.81% to -$295.0 million in 2020, then soared by 95.93% to -$12.0 million in 2021, then crashed by 550.0% to -$78.0 million in 2022.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$78.0 million, -$12.0 million, and -$295.0 million for Q2 2022, Q2 2021, and Q1 2020 respectively.